Greater Kansas City Psychological Association is approved by the American Psychological Association to sponsor continuing education for psychologists. Greater Kansas City Psychological Association maintains responsibility for this program and its content.
_________________________________________
COVID-19 Impacts on Education and Training – Dr. Catherine Grus
Presentation Objectives:
- Participants will be able to describe the impacts of the COVID-19 pandemic on graduate and post-graduate education and training.
- Participants will be able to list three actions taken to mitigate the impact of COVID-19 pandemic on education and training.
- Participants will be able to discuss continued and future concerns about impacts of the COVID-19 pandemic on education and training.
This program will describe impacts of the COVID-19 pandemic on graduate and post graduate education and training. Actions taken by the American Psychological Association and the education and training community will be discussed. Areas of continued and future concerns will be reviewed.
About Dr. Grus
Dr. Grus is the Chief Education Officer at the American Psychological Association and has been on the staff of the APA since 2005. In her role as Chief Education Officer, she leads the association’s efforts to promote psychology in education and education in psychology. Dr. Grus completed her PhD in clinical psychology at Nova University, with an internship in pediatric psychology at the University of Miami School of Medicine Mailman Center for Child Development, and a postdoctoral fellowship at the University of North Carolina Chapel Hill School of Medicine.
Providing Addiction Services During a Pandemic: Lessons Learned from COVID-19 – Dr. Bruce Liese
Presentation Objectives:
- Learners will be able to describe the impact of the COVID-19 pandemic on people with substance use disorders (SUDs) and addictions.
- Learners will be able to describe the impact of the COVID-19 pandemic on SUDs and addiction treatment services.
- Learners will be able to list at least two strategies for addressing the clinical needs of people with SUDs and addictions during the current COVID-19 pandemic.
This presentation will share the many lessons learned in the development and expansion of safety net services for people with addictions, including the changes in how services are provided due to the impact of COVID-19.
About Dr. Liese
Dr. Liese, PhD, ABPP is a Professor of Family Medicine and Psychiatry at the University of Kansas Medical Center and Clinical Director of the Cofrin Logan Center for Addiction Research and Treatment at the University of Kansas. Dr. Liese served as President of APA Division 50 (Addiction Psychology) in 2017, Member-at-Large in 2018-2019, and he is now APA Council Representative for Division 50. His work focuses primarily on the diagnosis and treatment of addictive behaviors. Dr. Liese has taught courses on addictive behaviors and evidence-based practice, and he has supervised hundreds of psychotherapy trainees. Dr. Liese has more than 75 publications, and he has co-authored two texts on addictive behaviors. Dr. Liese has received a Presidential Citation from Division 50 for his 10-year Editorship of the Division newsletter. In 2015 he received the Distinguished Career Contributions to Education and Training award from APA Division 50, and he received an APA Presidential Citation for his work as a Citizen Psychologist at the APA Convention in 2018. In addition to his scholarly and administrative activities, Dr. Liese continues to provide individual and group psychotherapy to at least 20 patients per week.
Borderline Personality Disorder During the Pandemic: Treatment and Other Considerations – Dr. Reed Maxwell
Presentation Objectives:
- Providers will learn 1-2 areas of potential pandemic-related lifestyle changes on experiences of persons with Borderline Personality Disorder.
- Providers will learn 1-2 areas of impact to telehealth treatments and therapeutic alliances with persons with Borderline Personality Disorder.
- Providers will learn 1-2 techniques about telehealth interventions useful for persons with Borderline Personality Disorder.
This presentation will address how the ongoing pandemic impacts Borderline Personality Disorder and its treatment.
About Dr. Maxwell
Dr. Maxwell is an assistant professor in the Department Psychiatry and Behavioral Sciences at the University of Kansas Medical Center. Prior to coming to KU Medical Center, Dr. Maxwell was a psychoanalytic fellow at the Center for Psychoanalytic Training and Research at Columbia University in New York. He also spent two years as a postdoctoral associate of psychology in psychiatry at the Personality Disorders Institute at Cornell University/Weill Cornell Medicine, where he also was a research coordinator. Dr. Maxwell earned a doctorate in clinical psychology from Binghamton University State University of New York and completed a clinical psychology internship at the University of Rochester Medical School. He holds a master's degree from Binghamton University, a bachelor's degree in psychology from Kansas State University and a bachelor's degree in English literature from the University of Kansas. A rising scholar, Dr. Maxwell has a dozen publications to his credit and has lectured at workshops and conferences around the nation. His research interests include personality psychopathology (e.g., borderline personality organization) and its treatment, as well as dissociation, emotion dysregulation and hypnotic susceptibility.
Telepsychology: Relevant History, COVID-19 Response, and Beyond – Dr. Shawna Wright
Presentation Objectives:
- Describe relevant history of telepsychology including pertinent aspects of state law and licensure requirements of telepsychology prior to the COVID-19 public health emergency.
- Identify relevant legislative and policy waivers that informed the deployment and utilization of telepsychology during the COVID-19 pandemic.
- Explain relevant best-practices and telebehavioral health competencies that will inform the future of telepsychology practice.
This program will provide a brief overview of the history of telehealth, including basic terminology, applications and regulations. Participants will learn about policy and legislative actions that were implemented to increase the availability of telepsychology services in response to COVID-19. Introductory-level best practices and telebehavioral health competencies will be described and reviewed. Finally, the future of telepsychology practice (post-pandemic) will be discussed, and participants will be informed of relevant issues and topics to study as they build business plans that include telepsychology practice.
About Dr. Wright
Shawna Wright, Ph.D., is the Associate Director of the University of Kansas Center for Telemedicine & Telehealth and is a licensed psychologist. She obtained her graduate training in clinical psychology at Texas Tech University. Dr. Wright worked for over a decade in community mental health and has expertise in treating rural and underserved populations. She is the president and CEO of Wright Psychological Services, an independent telepsychology practice that was established in 2011 to provide assessment and treatment to residents of rural skilled nursing facilities. Through her experience with providing treatment to rural and underserved populations, Dr. Wright is acutely aware of the impact of the shortage of medical and mental health providers, and she sees the promise of telehealth for improving access to care. She has interests in advancing telehealth policy and engaging medical and mental health professionals and students in telemedicine education. Dr. Wright works with KUMC’s Project ECHO as project facilitator and behavioral health content expert to assist Kansas health/mental health providers with increasing access to up-to-date research outcomes, pest practices, and standards of care to reduce health disparities. Dr. Wright is a member of the Rural and Frontier Subcommittee of the Kansas Governor’s Behavioral Health Services Planning Council, the Kansas State Epidemiological Outcomes Workshop, and the Kansas Prescription Drug and Opioid Advisory Committee. She works with these groups to understand gaps in access to care and to identify ways telemedicine can be leveraged to increase health equity in Kansas.
